(Lectures and Speeches) The 29th General Assembly of the Japan Medical Congress 2015 Kansai (April 12, 2015)
date : 4/12/2015
Dr.
Miyata Toshio, an Executive Director of HGPI, presented his view as one
of the panelists.‘Restriction and Flexible Practice on Japan’s Good
Clinical Practice (GCP) in Promoting Clinical Research: What Japan
Should do for Winning in New Drug Development market’
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
